Dolby Laboratories Quarterly Income Statement
NYSE: DLBMiscellaneousMulti-Sector CompaniesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Dolby Laboratories revenue and earnings
In the quarter ended Jun 26, 2026, Dolby Laboratories generated $305.0 million in revenue, down 3.3% from the same quarter a year earlier. Net income was $28.6 million (-37.9% year over year), for a net margin of 9.4% versus a median of 16.1% in the prior 5 quarters. Gross margin was 86.8% (up from 86.1%) and operating margin 11.3%.
Diluted earnings per share came in at $0.30, down from $0.48.
Summary generated from market data by MetaCap's automated system. Methodology
Dolby Laboratories income statement (quarterly)
| Quarter (USD) | Q3 20262026-06-26 | Q2 20262026-03-27 | Q1 20262025-12-26 | Q4 20252025-09-26 | Q3 20252025-06-27 | Q2 20252025-03-28 | Q1 20252024-12-27 | Q4 20242024-09-27 | Q3 20242024-06-28 | Q2 20242024-03-29 | Q1 20242023-12-29 | Q4 20232023-09-29 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 305.00M | 395.63M | 346.71M | 307.02M | 315.55M | 369.56M | 357.00M | 304.81M | 288.82M | 364.52M | 315.57M | 290.56M |
| Revenue growth (YoY) | -3.34% | +7.05% | -2.88% | +0.73% | +9.25% | +1.38% | +13.13% | +4.90% | -3.20% | -3.02% | -5.78% | +4.44% |
| Cost of Revenue | 40.32M | 44.73M | 43.21M | 39.52M | 44.00M | 35.84M | 40.77M | 34.00M | 35.66M | 38.78M | 32.06M | 35.55M |
| Gross Profit | 264.68M | 350.90M | 303.50M | 267.50M | 271.54M | 333.72M | 316.23M | 270.81M | 253.16M | 325.75M | 283.51M | 255.01M |
| Operating Expenses | 230.36M | 237.95M | 241.34M | 237.83M | 223.91M | 225.96M | 236.34M | 224.46M | 216.37M | 216.78M | 217.29M | 258.50M |
| Research & Development | 65.75M | 63.65M | 69.08M | 67.47M | 65.98M | 61.71M | 66.64M | 68.64M | 65.50M | 62.49M | 67.03M | 70.43M |
| Selling, General & Admin | 160.66M | 172.12M | 161.79M | 164.24M | 158.47M | 160.04M | 164.49M | 157.11M | 146.79M | 156.78M | 144.17M | 157.48M |
| Operating Income | 34.32M | 112.95M | 62.16M | 29.68M | 47.64M | 107.76M | 79.88M | 46.35M | 36.78M | 108.97M | 66.22M | -3.49M |
| Other Income (Expense) | 9.49M | 6.75M | 9.44M | 11.99M | 7.88M | 12.49M | 6.17M | 13.38M | 13.38M | 12.78M | 14.61M | 12.53M |
| Pretax Income | 43.80M | 119.70M | 71.60M | 41.67M | 55.52M | 120.25M | 86.05M | 59.73M | 50.16M | 121.75M | 80.83M | 9.03M |
| Income Tax | 14.59M | 24.25M | 17.92M | -8.01M | 8.97M | 28.02M | 17.98M | 868.00K | 10.51M | 23.53M | 13.25M | -875.00K |
| Net Income | 28.60M | 94.92M | 53.33M | 49.33M | 46.07M | 91.79M | 67.82M | 58.57M | 38.44M | 97.83M | 66.98M | 9.19M |
| Net Income growth (YoY) | -37.92% | +3.40% | -21.37% | -15.77% | +19.84% | -6.17% | +1.26% | +537.60% | +134.43% | +2.23% | -15.61% | -66.90% |
| EPS (Basic) | 0.30 | 1.00 | 0.56 | 0.52 | 0.48 | 0.95 | 0.71 | 0.62 | 0.40 | 1.02 | 0.70 | 0.10 |
| EPS (Diluted) | 0.30 | 0.99 | 0.55 | 0.50 | 0.48 | 0.94 | 0.70 | 0.59 | 0.40 | 1.01 | 0.69 | 0.08 |
| Shares Outstanding (Basic) | 94.24M | 95.22M | 95.47M | — | 95.90M | 96.33M | 95.61M | — | 95.69M | 95.72M | 95.38M | — |
| Shares Outstanding (Diluted) | 94.52M | 95.52M | 96.52M | — | 96.90M | 97.47M | 97.15M | — | 96.96M | 96.86M | 97.44M | — |
| EBITDA | 56.92M | 137.04M | 86.31M | 51.67M | 69.57M | 129.30M | 102.24M | 67.71M | 55.09M | 126.99M | 84.09M | 17.64M |
| Gross Margin | 86.78% | 88.69% | 87.54% | 87.13% | 86.06% | 90.30% | 88.58% | 88.85% | 87.65% | 89.36% | 89.84% | 87.76% |
| Operating Margin | 11.25% | 28.55% | 17.93% | 9.67% | 15.10% | 29.16% | 22.38% | 15.21% | 12.74% | 29.89% | 20.98% | -120.00% |
| Net Margin | 9.38% | 23.99% | 15.38% | 16.07% | 14.60% | 24.84% | 19.00% | 19.22% | 13.31% | 26.84% | 21.23% | 3.16% |
This table shows 12 quarterly periods of Dolby Laboratories's income statement, from Q3 2026 back to Q4 2023, across 20 line items including revenue, cost of revenue, gross profit. Values in USD; B = billions, M = millions. Fiscal periods follow DLB's reporting calendar. What is a income statement?